(1) The general assembly finds, determines, and declares that: (a) Prescription drug misuse occurs in this country to an extent that exceeds or rivals the abuse of illicit drugs;(b) Prescription drug misuse occurs at times due to the deception of the authorized practitioners where patients seek controlled substances for treatment and the practitioner is unaware of the patient's other medical providers and treatments;(c) Electronic monitoring of prescriptions for controlled substances provides a mechanism whereby practitioners can discover the extent of each patient's requests for drugs and whether other providers have prescribed similar substances during a similar period of time;(d) Electronic monitoring of prescriptions for controlled substances provides a mechanism for law enforcement officials and regulatory boards to efficiently investigate practitioner behavior that is potentially harmful to the public.Renumbered from C.R.S. § 12-42.5-401 and amended by 2019 Ch. 136, § 1, eff. 10/1/2019.Amended by 2017 Ch. 263, § 86, eff. 5/25/2017.L. 2012: Entire article added with relocations, (HB 12-1311), ch. 281, p. 1590, § 1, effective July 1. L.

nd amended by 2019 Ch. 136, § 1, eff. 10/1/2019.Amended by 2017 Ch. 263, § 86, eff. 5/25/2017.L. 2012: Entire article added with relocations, (HB 12-1311), ch. 281, p. 1590, § 1, effective July 1. L. 2017: (1)(a) and (1)(b) amended, (SB 17-242), ch. 263, p. 1286, § 86, effective May 25.This section is similar to former § 12-42.5-401 as it existed prior to 2019.